113 related articles for article (PubMed ID: 36813756)
1. Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands.
Costanzo G; Patamia V; Turnaturi R; Parenti C; Zagni C; Lombino J; Amata E; Marrazzo A; Pasquinucci L; Rescifina A
Chem Biol Drug Des; 2023 Jun; 101(6):1382-1392. PubMed ID: 36813756
[TBL] [Abstract][Full Text] [Related]
2. (2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist.
Pasquinucci L; Turnaturi R; Calò G; Pappalardo F; Ferrari F; Russo G; Arena E; Montenegro L; Chiechio S; Prezzavento O; Parenti C
Eur J Med Chem; 2019 Apr; 168():189-198. PubMed ID: 30822708
[TBL] [Abstract][Full Text] [Related]
3. Development of novel LP1-based analogues with enhanced delta opioid receptor profile.
Pasquinucci L; Turnaturi R; Prezzavento O; Arena E; Aricò G; Georgoussi Z; Parenti R; Cantarella G; Parenti C
Bioorg Med Chem; 2017 Sep; 25(17):4745-4752. PubMed ID: 28734666
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of N-substituent structural variations in opioid receptor profile of LP1.
Pasquinucci L; Turnaturi R; Aricò G; Parenti C; Pallaki P; Georgoussi Z; Ronsisvalle S
Bioorg Med Chem; 2016 Jun; 24(12):2832-42. PubMed ID: 27234885
[TBL] [Abstract][Full Text] [Related]
5. The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment.
Pasquinucci L; Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Ronsisvalle G
Life Sci; 2012 Jan; 90(1-2):66-70. PubMed ID: 22100511
[TBL] [Abstract][Full Text] [Related]
6. LP1 and LP2: Dual-Target MOPr/DOPr Ligands as Drug Candidates for Persistent Pain Relief.
Pasquinucci L; Parenti C; Georgoussi Z; Reina L; Tomarchio E; Turnaturi R
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299443
[TBL] [Abstract][Full Text] [Related]
7. An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain.
Ronsisvalle S; Aricò G; Panarello F; Spadaro A; Pasquinucci L; Pappalardo MS; Parenti C; Ronsisvalle N
Bioorg Med Chem; 2016 Nov; 24(21):5280-5290. PubMed ID: 27624520
[TBL] [Abstract][Full Text] [Related]
8. Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand.
Parenti C; Turnaturi R; Aricò G; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Life Sci; 2012 Jun; 90(25-26):957-61. PubMed ID: 22580287
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists.
Turnaturi R; Parenti C; Prezzavento O; Marrazzo A; Pallaki P; Georgoussi Z; Amata E; Pasquinucci L
Molecules; 2018 Mar; 23(3):. PubMed ID: 29547588
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the Power of Stereochemistry in Drug Action: 3-[(2
Turnaturi R; Pasquinucci L; Chiechio S; Grasso M; Marrazzo A; Amata E; Dichiara M; Prezzavento O; Parenti C
ACS Chem Neurosci; 2020 Apr; 11(7):999-1005. PubMed ID: 32186844
[TBL] [Abstract][Full Text] [Related]
11. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures.
Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L
Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722
[TBL] [Abstract][Full Text] [Related]
12. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
13. Novel
Turnaturi R; Chiechio S; Pasquinucci L; Spoto S; Costanzo G; Dichiara M; Piana S; Grasso M; Amata E; Marrazzo A; Parenti C
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014375
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Structure-Activity Relationships of (-)-
Pasquinucci L; Parenti C; Amata E; Georgoussi Z; Pallaki P; Camarda V; Calò G; Arena E; Montenegro L; Turnaturi R
Pharmaceuticals (Basel); 2018 May; 11(2):. PubMed ID: 29734749
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
Zhou Q; Duan WH; Cohen DJ; Bidlack JM; Wentland MP
Yao Xue Xue Bao; 2003 Oct; 38(10):748-53. PubMed ID: 14730897
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation.
Pasquinucci L; Turnaturi R; Montenegro L; Caraci F; Chiechio S; Parenti C
Eur J Pharmacol; 2019 Mar; 847():97-102. PubMed ID: 30690004
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain.
Vicario N; Pasquinucci L; Spitale FM; Chiechio S; Turnaturi R; Caraci F; Tibullo D; Avola R; Gulino R; Parenti R; Parenti C
Mol Neurobiol; 2019 Nov; 56(11):7338-7354. PubMed ID: 31030416
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
May EL; Jacobson AE; Mattson MV; Traynor JR; Woods JH; Harris LS; Bowman ER; Aceto MD
J Med Chem; 2000 Dec; 43(26):5030-6. PubMed ID: 11150174
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of N-substitution in 6,7-benzomorphan compounds.
Pasquinucci L; Prezzavento O; Marrazzo A; Amata E; Ronsisvalle S; Georgoussi Z; Fourla DD; Scoto GM; Parenti C; Aricò G; Ronsisvalle G
Bioorg Med Chem; 2010 Jul; 18(14):4975-82. PubMed ID: 20599386
[TBL] [Abstract][Full Text] [Related]
20. New benzomorphan derivatives of MPCB as MOP and KOP receptor ligands.
Pasquinucci L; Iadanza M; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Parenti C; De Luca L; Ronsisvalle G
Pharmazie; 2007 Nov; 62(11):813-24. PubMed ID: 18065096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
